Journals / Turkish Journal of Obstetrics and Gynecology / 2020 / Cilt: 17 - Sayı: 3

The impact of morbid obesity on survival of endometrial cancer

Morbid obezitenin endometriyal kanserli hastaların sağkalımına etkisi

Pages
209–214
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These patients were stratified into two groups according to their body mass index,

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Morbid obesity is identified as patients with a body mass index more than 40 kg/m2.
📊
Key Findings & Data:Obesity is known as a risk factor for endometrial cancer due to the increase of the deposited estrogen.
💡
Conclusion & Impact:These patients were stratified into two groups according to their body mass index,
🔬Design:Review & Systematic Survey
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Morbid obesity is identified as patients with a body mass index more than 40 kg/m2. Obesity is known as a risk factor for endometrial cancer due to the increase of the deposited estrogen. This study was conducted to evaluate the effect of morbid obesity on the survival of endometrial cancer.Materials and Methods: The archival records and pathologic reports of patients with endometrial cancer who underwent surgery and were followed up in Çukurova University Gynecologic Oncology Center between January 1996 and December 2018 were reviewed, retrospectively. Data regarding body mass index and survival was reported in 520 patients. These patients were stratified into two groups according to their body mass index,

Özet

Amaç: Morbid obezite, vücut kitle indeksi 40 kg/m2’den fazla olan hastaları tanımlar. Obezite, yağ dokusunda depolanan östrojenin artışı nedeniyle endometriyum kanseri için bir risk faktörü olarak bilinir. Bu çalışma, endometriyal kanserin sağkalımı üzerine morbid obezite etkisini değerlendirmek için planlanmıştır.Gereç ve Yöntemler: Çukurova Üniversitesi Jinekolojik Onkoloji Birimi’nde Ocak 1996 - Aralık 2018 tarihleri arasında opere edilen ve takip edilen endometriyum kanserli olgularının arşiv kayıtları ve patolojik raporları retrospektif olarak incelendi. Bu hastalardan vücut kitle indeksi ve sağkalım ile ilgili tam verilerine ulaşılabilen 520 olgu çalışmaya dahil edildi. Hastalar vücut kitle indeksleri

🔖

Cite This Article

GÜMÜRDÜLÜ, D., KHATİB, G., GÜLEÇ, Ü. K., GÜZEL, A. B., VARDAR, M. A. (2022). The impact of morbid obesity on survival of endometrial cancer. Turkish Journal of Obstetrics and Gynecology, Cilt: 17 - Sayı: 3, 209–214. https://ajindex.com/articles/612957

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505
  2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-7
  3. Arem H, Irwin ML. Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond) 2013;37:634-9
  4. Pavelka JC, Ben-Shachar I, Fowler JM, Ramirez NC, Copeland LJ, Eaton LA, et al. Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 2004;95:588-92
  5. Gunderson CC, Java J, Moore KN, Walker JL. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 2014;133:23-7
  6. Bouwman F, Smits A, Lopes A, Das N, Pollard A, Massuger L, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol Oncol 2015;139:369-76
  7. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253
  8. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009;114:121-7
  9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38
  10. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134
  11. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009;105:109
  12. Clarke BA, Gilks CB. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol 2010;63:410-5
  13. Temkin SM, Pezzullo JC, Hellmann M, Lee YC, Abulafia O. Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol 2007;30:8-14. 14. von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 2006;107:2786-91
  14. Bittoni MA, Fisher JL, Fowler JM, Maxwell GL, Paskett ED. Assessment of the effects of severe ob